Australian Pharmaceuticals & Biotech High Insider Buying

Results

2 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

21 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MSB Mesoblast	AU$1.85	8.5%	487.3%	AU$2.1b	AU$1.46	PS232.2x	E61.5%	n/a
IMM Immutep	AU$0.33	4.8%	4.8%	AU$472.7m	AU$0.95	PS123x	E38.6%	n/a
ARX Aroa Biosurgery	AU$0.70	4.5%	6.1%	AU$238.0m	AU$0.95	PS3.5x	E59.7%	n/a
PAR Paradigm Biopharmaceuticals	AU$0.49	-4.8%	26.9%	AU$180.0m	AU$0.85	PB7.3x	E-13.2%	n/a
TRJ New Trajan Group Holdings	AU$1.04	-1.4%	-22.2%	AU$153.8m	AU$1.40	PS1x	E99.2%	n/a
ACW Actinogen Medical	AU$0.031	24.0%	31.9%	AU$85.4m	n/a	PS9.2x	E-22.1%	n/a
NUZ Neurizon Therapeutics	AU$0.18	-2.7%	80.0%	AU$85.2m	AU$0.56	PS104.1x	S58.2%	n/a
PER New Percheron Therapeutics	AU$0.072	5.9%	26.3%	AU$76.3m	AU$0.21	PS25.7x	E19.8%	n/a
TYP Tryptamine Therapeutics	AU$0.04	-11.1%	n/a	AU$61.3m	n/a	PS38.5x	n/a	n/a
RAD Radiopharm Theranostics	AU$0.028	0%	-60.6%	AU$60.8m	AU$0.24	PS31.1x	E10.9%	n/a
SPL Starpharma Holdings	AU$0.12	0%	-14.8%	AU$48.0m	n/a	PS4.9x	n/a	n/a
BDX BCAL Diagnostics	AU$0.10	0%	5.0%	AU$37.7m	AU$0.20	PS12.2x	E90.6%	n/a
LGP Little Green Pharma	AU$0.13	-7.4%	0%	AU$34.8m	AU$0.17	PS1.3x	E141.2%	n/a
PTX Prescient Therapeutics	AU$0.042	10.5%	-53.8%	AU$33.8m	AU$0.14	PS9.1x	n/a	n/a
ATX Amplia Therapeutics	AU$0.083	-9.8%	12.2%	AU$22.8m	AU$0.24	PS6.7x	n/a	n/a
AGH Althea Group Holdings	AU$0.034	-12.8%	-10.5%	AU$17.3m	n/a	PS0.6x	n/a	n/a
EMD Emyria	AU$0.038	-2.6%	-44.1%	AU$16.6m	n/a	PS7.2x	n/a	n/a
RGT Argent BioPharma	AU$0.24	0%	-58.6%	AU$13.0m	n/a	PS14.6x	n/a	n/a
EOF Ecofibre	AU$0.032	-23.8%	-69.5%	AU$11.7m	n/a	PS0.4x	n/a	n/a
RNO Rhinomed	AU$0.04	-7.0%	-55.6%	AU$11.5m	n/a	PS1.4x	n/a	n/a
1AD AdAlta	AU$0.018	0%	-21.7%	AU$11.4m	n/a	PS6.5x	n/a	n/a

Page 1 of 1